An open-label, multicenter, Post-Marketing Requirement

Project: Research project

Project Details

Description

An open-label, multicenter, Post-Marketing Requirement study to investigate the safety and tolerability of octaplas (TM) in the management of pediatric patients who require therapeutic plasma exchange
StatusFinished
Effective start/end date2/20/151/1/20

Funding

  • OCTAPHARMA USA, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.